Sign inGet started

Research and product fit

Why RxID works in the real world

This page groups the key healthcare workflow problems, the evidence behind them, and the exact RxID features that solve them. It also covers the parts where RxID improves an already working process.

A. Trust and authenticity gaps

  1. No national prescription monitoring backbone

    India has no centralized PDMP style layer with nationwide prescription lifecycle checks across doctor, pharmacist, and patient touchpoints. [1][2]

  2. Telemedicine PDF prescriptions are easy to fake

    Telemedicine is expanding at 24% CAGR, but a plain PDF has no cryptographic proof of origin or integrity. [2][3]

  3. Reuse and lifecycle abuse at the counter

    Paper copies and screenshots can be reused because most counters do not have a real-time lifecycle check. [4]

How RxID addresses this

RxID signs every prescription payload with HMAC, attaches QR identity, enforces status checks (VALID, EXPIRED, INVALIDATED, NO_REFILLS_LEFT, SIGNATURE_MISMATCH), and records every state change in an append-only audit trail.

B. Dispensing quality and safety gaps

  1. Dispensing error load is high

    Audit studies report 41% dispensing error rates in sampled prescriptions, with 63.7% tied to brand or strength substitution errors. [4][5]

  2. Interaction risk rises with polypharmacy

    DDIs are reported in around 1 in 3 to 40% of multi-drug prescriptions, while polypharmacy prevalence in urban elderly cohorts reaches 33.7%. [6][7][8]

  3. Potentially inappropriate medicines remain common

    28.8% of elderly prescriptions include potentially inappropriate medicines. [8]

How RxID addresses this

RxID delivers pharmacist-side verification details, AI dispensing brief, brand substitution guidance, deterministic dose anomaly flags, and patient active-medication interaction checks from historical prescriptions.

C. Affordability, adherence, and continuity gaps

  1. Medicines dominate household healthcare spend

    Medicines account for about 69 to 70% of out-of-pocket healthcare spend in India, with rural medicine spend reported as high as 77%. [9]

  2. Essential medicine access and adherence remain weak

    60% of Indians lack regular access to essential medicines, and non-adherence estimates range from 18.7% to 74%. [10][11]

  3. Doctor visibility into real adherence is poor

    Physician-perceived adherence can be near 40%, while measured incidence has reached 85% in reported studies. [12]

How RxID addresses this

RxID improves continuity with plain-language explainers, deterministic medication schedules, refill signals, patient sharing controls, caregiver profile support, and generic affordability signals tied to NLEM metadata.

Enhancements even when there is no immediate problem

  • • Doctor, pharmacist, patient, and admin workflows are role-scoped and fast on mobile and desktop.
  • • Unregistered patients are fully supported without forcing account creation.
  • • Critical actions have confirmation steps, detailed audit logging, and human-readable statuses.
  • • Demo mode gives full live flow experience and resets daily for clean trials.

AI baked in

Doctor AI

Regimen autocomplete · Patient history summary · Pre-submission drug review · Handwritten prescription scan

Pharmacist AI

Dispensing brief at scan result · Brand substitution assistant · Dose anomaly highlighting · Prescription-scoped pharmacist chat

Patient AI

Plain language medication explainer · Medication schedule timeline · Interaction warning from active medications · Regional language support path

Implemented feature coverage

Core trust and security

  • • HMAC-signed QR payloads with constant-time verification
  • • Role-based access control across doctor, pharmacist, patient, admin
  • • Rate limiting on sensitive endpoints
  • • Append-only audit logging with actor, action, metadata, and IP
  • • Server-enforced expiry and schedule controls for H1 and X drugs

Doctor and prescription lifecycle

  • • Structured prescription creation with diagnosis, schedules, refills, and validity
  • • Post-create QR and PDF generation
  • • Prescription invalidation with required reason
  • • Doctor-side list and detail views with status lifecycle
  • • Optional patient linking with support for unregistered patients

Pharmacist, patient, and admin operations

  • • QR scan and manual fallback verification flow with explicit confirm-dispense
  • • Pharmacist history, fail-mark window, and profile controls
  • • Patient read-only view, privacy toggles, and controlled account deletion
  • • Admin dashboards for users, prescriptions, audit, anomaly panels, and CSV exports
  • • In-app notifications with unread badge and mark-all-read

Data and intelligence layer

  • • Regimen, dose range, and interaction datasets for deterministic checks
  • • AI provider routing with fallbacks and graceful degradation
  • • Creation-time generation of patient explainers and dispensing brief
  • • NLEM generic availability metadata and chronic refill support
  • • Demo accounts with daily reseed and instant role-based trial flow

References

  1. [1] ABDM public documentation and architecture context
  2. [2] NHA ABDM ecosystem dashboard
  3. [3] Telemedicine Practice Guidelines (India, 2020 framework context)
  4. [4] IOSR Journal: Misuse and abuse of prescription drugs
  5. [5] JPRI 2021: Prescription audit and dispensing error analysis
  6. [6] JPTCP 2024: Drug-drug interaction burden in tertiary care setting
  7. [7] PMC11791031: Polypharmacy prevalence and geriatric risk context
  8. [8] PMC8653485: Outcomes linked to polypharmacy in Indian elderly populations
  9. [9] PMC12715599: Out-of-pocket spending and medicine affordability context
  10. [10] PMC3573605: Essential medicine access and expenditure context
  11. [11] PMC11653035: Medication non-adherence range in Indian chronic care
  12. [12] PMC5788401: Physician perception versus measured adherence incidence